Clinical Trial Detail

NCT ID NCT02921919
Title Open-Label Extension and Safety Study of Talazoparib
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Medivation, Inc.
Indications

Advanced Solid Tumor

hematologic cancer

Therapies

Talazoparib

Age Groups: child senior adult

No variant requirements are available.